<DOC>
	<DOC>NCT02468336</DOC>
	<brief_summary>The objective of this study is to demonstrate that the investigational device, AngioDefender, is comparable to the established procedure referred to as 'brachial artery ultrasound imaging' in their abilities to quantify flow-mediated vasodilation of the brachial artery.</brief_summary>
	<brief_title>AngioDefender Versus Brachial Artery Ultrasound Imaging</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>ECOG 02 1. Body mass index (BMI) &gt;50 kg/m2 2. Midupper arm circumference of arm selected for FMD testing &lt;17 cm or &gt;40 cm 3. Sinus arrhythmia (RR intervals vary by &gt;50%), atrial fibrillation, atrial flutter, multifocal atrial tachycardia, frequent (&gt;1 per 10sec strip) premature atrial or ventricular contractions (isolated, nonisolated, or alternating), documented by 12lead ECG with rhythm strip at the time of subject screening. 4. Clinical signs and/or symptoms of active viral or bacterial infections 5. Resting tremor or inability to remain still for the duration of AD and BAUI testing 6. Systolic blood pressure (SBP) at rest of &gt;170 mmHg or diastolic blood pressure (DBP) at rest of â‰¥110 mmHg. 7. Previous intolerable adverse reaction(s) to vascular testing using an upper extremity occlusive pneumatic cuff</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Physiology</keyword>
</DOC>